Filter posts

United Health To Congress: Let Cancer Patients Eat Gauze (Op-Ed in The Hill)

Jonathan Wilcox’s op-ed in The Hill today highlights the growing challenge of insurance company tactics that …

BIO Principles on Expanded Access to Investigational, Unapproved Medicines

Seriously ill patients with limited or no alternative therapies, and who are ineligible or unable …

Dr. Petra Kaufmann Video Interview: Clinical and Translational Science Awards Program

Petra Kaufmann, MD, MSc, Director of the Division of Clinical Innovation at the National Institutes …

The Value of Innovation to Save and Transform Lives

Patients have greater hope for cures to today’s most complex and challenging diseases thanks to …

We Need Your Input: BIO Survey on Effective FDA-Sponsor Communication

BIO is surveying members and non-members on their interactions with the FDA during the various …

New PhRMA Report: A Decade of Innovation in Rare Diseases

Today, the Pharmaceutical Research and Manufacturers of America (PhRMA) released “A Decade of Innovation in …

Op-Ed: As I Lay Dying

Former staff writer for the LA Times Laurie Becklund shares her experience ‘climbing ladders and …

FOX Business: BIO CEO Jim Greenwood Discusses Future of Medicine

BIO President and CEO Jim Greenwood appeared on Fox Business during the 17th Annual BIO …

BIO CEO & Investor Conference Kicks Off in NYC

The 17th Annual BIO CEO & Investor Conference opened today with a record number of partnering …

How Industry Rates Interactions with the FDA

Kicking off day one of the BIO CEO & Investor Conference in New York City, …